IPG Mediabrands has launched Healix, a global division focused on Life Science and Healthcare brands. As part of the launch, Healix will have offices in United States with affiliates in EMEA and APAC regions.
Healix will dedicate resources to support the majority of IPG Mediabrands’ healthcare clients, with specialized expertise and forward-thinking support in this growing sector.
Utilizing data and proprietary analytics tools, Healix comprises pharmaceutical, biotechnology and nutraceuticals experts who examine issues, identify solutions, and provide media planning strategies.
“Healix is an evolution of our best-in-class services. The dynamic talent working at Healix is wholly committed to creating better business outcomes for healthcare brands, backed by our network’s expertise across media intelligence and innovation,” said Henry Tajer, Global CEO, IPG Mediabrands.
Healix represents numerous clientele who are at the forefront of the healthcare industry, all of whom are responsible for shaping the future of life sciences. Headquartered in New York, Healix will directly collaborate with IPG Mediabrands’ Specialist Business Units, including Society, Reprise, Ansible and Cadreon to ensure optimal client offerings and solutions.